PL117466B1 - Process for preparing novel derivatives of phenylopiperazine - Google Patents

Process for preparing novel derivatives of phenylopiperazine Download PDF

Info

Publication number
PL117466B1
PL117466B1 PL1977197550A PL19755077A PL117466B1 PL 117466 B1 PL117466 B1 PL 117466B1 PL 1977197550 A PL1977197550 A PL 1977197550A PL 19755077 A PL19755077 A PL 19755077A PL 117466 B1 PL117466 B1 PL 117466B1
Authority
PL
Poland
Prior art keywords
group
formula
carbon atoms
compound
defined above
Prior art date
Application number
PL1977197550A
Other languages
English (en)
Polish (pl)
Other versions
PL197550A1 (pl
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of PL197550A1 publication Critical patent/PL197550A1/xx
Publication of PL117466B1 publication Critical patent/PL117466B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40Radicals substituted by oxygen atoms
    • C07D307/42Singly bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PL1977197550A 1976-04-23 1977-04-22 Process for preparing novel derivatives of phenylopiperazine PL117466B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB16526/76A GB1575904A (en) 1976-04-23 1976-04-23 Phenyl piperazines

Publications (2)

Publication Number Publication Date
PL197550A1 PL197550A1 (pl) 1979-05-21
PL117466B1 true PL117466B1 (en) 1981-08-31

Family

ID=10078930

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1977197550A PL117466B1 (en) 1976-04-23 1977-04-22 Process for preparing novel derivatives of phenylopiperazine

Country Status (34)

Country Link
JP (1) JPS52151183A (fr)
AR (2) AR222003A1 (fr)
AT (1) AT355579B (fr)
AU (1) AU514822B2 (fr)
BE (1) BE853899A (fr)
BG (2) BG27746A3 (fr)
CA (1) CA1087617A (fr)
CH (2) CH633009A5 (fr)
CS (1) CS196360B2 (fr)
DD (1) DD129790A5 (fr)
DE (1) DE2717415A1 (fr)
DK (1) DK176177A (fr)
ES (2) ES457988A1 (fr)
FI (1) FI63937C (fr)
FR (1) FR2348925A1 (fr)
GB (1) GB1575904A (fr)
GR (1) GR64084B (fr)
HU (1) HU176820B (fr)
IE (1) IE44730B1 (fr)
IL (1) IL51787A (fr)
LU (1) LU77170A1 (fr)
MX (1) MX4596E (fr)
NL (1) NL7704456A (fr)
NO (1) NO146710C (fr)
NZ (1) NZ183715A (fr)
OA (1) OA05643A (fr)
PH (1) PH14124A (fr)
PL (1) PL117466B1 (fr)
PT (1) PT66452B (fr)
RO (1) RO72831A (fr)
SE (1) SE7704536L (fr)
SU (2) SU664564A3 (fr)
YU (1) YU104477A (fr)
ZA (1) ZA771849B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1601310A (en) * 1978-05-23 1981-10-28 Lilly Industries Ltd Aryl hydantoins
DE3142608A1 (de) * 1981-10-28 1983-05-05 Basf Ag, 6700 Ludwigshafen Polyazofarbstoffe
JPH07157477A (ja) * 1993-12-02 1995-06-20 Asahi Kagaku Kogyo Kk チアゾール誘導体の製造方法
WO1995024399A1 (fr) * 1994-03-11 1995-09-14 Yamanouchi Pharmaceutical Co., Ltd. Agoniste de recepteur 5-ht3, nouveau derive de thiazole et intermediaire destine a son obtention
GB9517381D0 (en) * 1995-08-24 1995-10-25 Pharmacia Spa Aryl and heteroaryl piperazine derivatives
CA2644069A1 (fr) 2006-02-28 2007-09-07 Helicon Therapeutics, Inc. Piperazines therapeutiques utilisees comme inhibiteurs de la pde4
US8927546B2 (en) 2006-02-28 2015-01-06 Dart Neuroscience (Cayman) Ltd. Therapeutic piperazines

Also Published As

Publication number Publication date
YU104477A (en) 1983-01-21
NL7704456A (nl) 1977-10-25
DK176177A (da) 1977-10-24
PH14124A (en) 1981-02-26
NO146710B (no) 1982-08-16
FI771287A (fr) 1977-10-24
BE853899A (fr) 1977-10-24
PL197550A1 (pl) 1979-05-21
PT66452A (en) 1977-05-01
ES467948A1 (es) 1978-11-01
PT66452B (en) 1979-03-09
DE2717415A1 (de) 1977-11-10
AU2438677A (en) 1978-10-26
RO72831A (fr) 1983-08-03
AR222635A1 (es) 1981-06-15
HU176820B (en) 1981-05-28
AR222003A1 (es) 1981-04-15
GB1575904A (en) 1980-10-01
AT355579B (de) 1980-03-10
IL51787A (en) 1980-02-29
JPS52151183A (en) 1977-12-15
CH633009A5 (en) 1982-11-15
SU727146A3 (ru) 1980-04-05
OA05643A (fr) 1981-04-30
NZ183715A (en) 1980-04-28
MX4596E (es) 1982-06-25
ATA285177A (de) 1979-08-15
AU514822B2 (en) 1981-02-26
ES457988A1 (es) 1978-07-16
IE44730B1 (en) 1982-03-10
CH625802A5 (en) 1981-10-15
CS196360B2 (en) 1980-03-31
FI63937C (fi) 1983-09-12
FI63937B (fi) 1983-05-31
CA1087617A (fr) 1980-10-14
NO146710C (no) 1982-11-24
ZA771849B (en) 1978-11-29
BG28055A3 (en) 1980-02-25
LU77170A1 (fr) 1979-01-18
FR2348925B1 (fr) 1980-04-11
IL51787A0 (en) 1977-05-31
GR64084B (en) 1980-01-21
SU664564A3 (ru) 1979-05-25
FR2348925A1 (fr) 1977-11-18
IE44730L (en) 1977-10-23
DD129790A5 (de) 1978-02-08
NO771398L (no) 1977-10-25
SE7704536L (sv) 1977-10-24
RO72831B (ro) 1983-07-30
BG27746A3 (en) 1979-12-12

Similar Documents

Publication Publication Date Title
US3991057A (en) C-Piperazino-pyridine sulfonamides
CS399991A3 (en) Amide derivatives
JPH07267964A (ja) 新規n−ヘテロ環状チエノチアジンカルボキシアミド、その製造方法及びその使用方法
HU213605B (en) Process for producing amide composition and pharmaceutical compositions comprising same as active ingredient
EP0183191A1 (fr) Dérivés de thiénylthiazole
EP1861079A1 (fr) Ethers arylsulfonyle benzyle utilises en tant qu'antagonistes 5-ht2a
CA1341314C (fr) Derives de benzimidazole, benzothiazole et benzoxazole
AU782993B2 (en) 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation
AU2005276233A1 (en) Diarylsulfones as 5-HT2A antagonists
US4769384A (en) Benzimidazole derivatives
US4156729A (en) 1,2-Benzisothiazolin-3-ones
PL117466B1 (en) Process for preparing novel derivatives of phenylopiperazine
JPS58203991A (ja) 2−フエニルイミダゾ〔4,5−c〕ピリジン類
US4123529A (en) Phenylpiperazine derivatives
DK168010B1 (da) Tetrahydroisoquinolinforbindelser og farmaceutisk middel indeholdende en saadan forbindelse
WO2011009826A2 (fr) Nouveaux dérivés de chalcone présentant une activité cytotoxique
US2958694A (en) 1-(aroylalkyl)-4-(2'-pyridyl) piperazines
US5276027A (en) Thiadiazinones
AU2012352572A1 (en) Benzisothiazol-3(1H)-one-5-sulfonyl derivatives as chemokine receptor modulators
PL123699B1 (en) Process for preparing novel derivatives of pyran-4-one
PL139497B1 (en) Process for preparing novel derivatives of 1-/2-hydroxyphenyl/-alkanals and alkanones
US4190663A (en) Anti-thrombotic 1,2-benzisothiazolin-3-ones
EP0030835B1 (fr) Dérivés de 6-phényl-3(2H)-pyridazinones substituées en position 2, leur production et compositions pharmaceutiques les contenant
PL164152B1 (pl) Sposób wytwarzania nowych pochodnych 2-iminobenzotiazoliny PL
EP0459748A2 (fr) Dérivés de la thien-2-ylméthylurée comme inhibiteurs des leukotrienes